Global Opportunities 2022/10/28 Istantanea del mercato pakistano delle infrastrutture Con una popolazione di oltre 230 milioni, il Pakistan ha un grande potenziale in qualità di mercato in crescita e un’enorme necessità di aggiorna...
Webinar Webinar: il meccanismo di adeguamento del carbonio alle frontiere (CBAM) spiegato alle aziende svizzere 2024/06/18 10:00–11:00
Country Consulting Export consulting Central Europe (Poland, Czech Republic, Slovakia & Hungary) 2024/05/21–2024/12/23 Zürich Schweiz
Global Opportunities 2021/04/20 Opportunities in the field of telemedicine The following article is a sneak peek of the report about medtech market in Central Eastern Europe prepared by Swiss Business Hub Central Europe....
Fact Sheet 2022/08/30 EU Directives RoHS and WEEE: This is what Swiss firms need to know The EU directives RoHS II (2011/65/EU) and WEEE (2012/19/EU) of the European Commission restrict the usage of hazardous substances in electr...
Country Consulting Export Consulting Pakistan Benefit from the expertise of proven experts 2024/08/26–2024/08/30 Zürich Schweiz
Market information 2024/03/21 Czech Republic The Czech Republic is one of the most industrialized economies in the European Union and shares many characteristics with Switzerland, such as a ...
Swiss Can AG Machines and complete machine lines to fill and seam cans and jars with powder and dry products
Export Knowhow 2021/08/17 Market Snapshot: Agriculture in Pakistan With a population of over 220m, Pakistan is the fifth most populous country in the world - with an annual estimated population growth rate of 2.0...
Industry Report 2022/02/28 Pakistan’s Medtech and digital health market With a roughly 220 million population Pakistan has a growing healthcare market, thanks to rapid urbanization, rising middle class and increasing ...
Länderberatungen Exportberatung Pakistan Mit Fachleuten aus unserem globalen Netzwerk 2024/08/26–2024/08/30 Zürich Schweiz
AlveoliX AG Life sciences / Biotech / Organs-on-chip / In vitro / Preclinical / Durg Discovery / Drug Development / Animal alternative / MPS